Research article · 2016
Conference abstractPublished 28 Nov 2016
Leveraging process characterization, manufacturing process history, and facility fit considerations to improve cell culture process performance
Bristol Myers Squibb, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In commercial manufacturing of biopharmaceutical products using mammalian cell culture bioprocessing, variation in bioreactor product titer could have a significant impact on drug substance yield without having a significant effect on drug substance critical quality attributes. Variation in titer presents potential drug supply challenges to an organization and its patients. At commercial scale, applying any mitigation strategy to alleviate variation in bioreactor product titer faces technical challenges for manufacturing processes that utilize semi-defined production media, varying production scales, different process technologies, and multiple manufacturing facilities. The contribution of raw material lot-to-lot variability in semi-defined production media on product titer is well-documented. Mitigating variation in product titer due to raw material lot-to-lot variability involves considerable in-house investment in time and resources as well as collaborations with vendors and external partners. In this presentation, we mitigated the impact of raw material lot-to-lot variability on bioreactor product titer by leveraging process characterization information, manufacturing process history analysis, and facility fit considerations to improve bioreactor product titer by 10% while maintaining product quality.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 26 Oct 2015
Overcome challenges in manufacture of biosimilars through media/feed screening and cell culture process optimization
Conference abstract · 26 Oct 2015
OvercomeChallenges to Manufacture ofBiosimilars through Media/FeedScreening and Cell Culture Process Optimization
Conference abstract · 26 Oct 2015
CMC Consideration for Biosimilar Drug Development and Manufacturing Process
Research article · 7 Jan 2022
History of the electoral legislation of the Republic of Uzbekistan and the election process of the President of the Republic of Uzbekistan
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectSocial Sciences & Humanities
- SubjectEngineering
- BylineArticles whose byline prints “Edward Crabbe”
